BioLineRx Ltd. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Modi In
SEC filing record 1 source field available
Fiscal year end
31 December
BioLineRx Ltd. has filed 604 SEC EDGAR filings since 24 Sep 2010

SEC filing history

Showing 176-200 of 604 matching filings.

Per page
25
Current page
8
6-K File 001-35223

6-K

Filing date
03 Jun 2020
Reporting date
03 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-86614

AMENDMENT NO. 1 TO THE SCHEDULE 13G

Filing date
02 Jun 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35223

6-K

Filing date
01 Jun 2020
Reporting date
01 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-222332

424B5

Filing date
28 May 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35223

6-K

Filing date
28 May 2020
Reporting date
28 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35223

6-K

Filing date
27 May 2020
Reporting date
27 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-86614

SABBYY 13G BLRX 5.26.20

Filing date
26 May 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35223

6-K

Filing date
26 May 2020
Reporting date
26 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35223

6-K

Filing date
26 May 2020
Reporting date
26 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35223

6-K

Filing date
20 May 2020
Reporting date
20 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-222332

424B5

Filing date
17 Apr 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-35223

CT ORDER filing

Filing date
23 Mar 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35223

6-K

Filing date
12 Mar 2020
Reporting date
12 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35223

6-K

Filing date
05 Mar 2020
Reporting date
05 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35223

6-K

Filing date
27 Feb 2020
Reporting date
27 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-35223

CT ORDER filing

Filing date
19 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-86614

THE SCHEDULE 13G

Filing date
14 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-86614

BIOLINERX LTD.

Filing date
07 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35223

6-K

Filing date
30 Jan 2020
Reporting date
30 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35223

6-K

Filing date
22 Jan 2020
Reporting date
22 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35223

6-K

Filing date
14 Jan 2020
Reporting date
14 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-35223

CT ORDER filing

Filing date
13 Dec 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35223

6-K

Filing date
13 Dec 2019
Reporting date
13 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35223

6-K

Filing date
05 Dec 2019
Reporting date
05 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .